Search research articles
Contact Us
Filters
Showing results (41-50 of 135) with videos related to
Page
of 14
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
June 15, 2010
Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet
Krishna M Boini, Chun Zhang, Min Xia, et al.
Journal of Clinical Laboratory Analysis
|
July 20, 2012
Detection and quantification of tricyclic antidepressants and other psychoactive drugs in urine by HPLC/MS/MS for pain management compliance testing
Justin L Poklis, Carl E Wolf, Ashley Goldstein, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 27, 2017
Ethanol Reversal of Tolerance to the Antinociceptive Effects of Oxycodone and Hydrocodone
Joanna C Jacob, Justin L Poklis, Hamid I Akbarali, et al.
Drug Testing and Analysis
|
September 4, 2013
Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication
Justin L Poklis, Carol R Nanco, Michelle M Troendle, et al.
Journal of Analytical Toxicology
|
September 18, 2015
Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper
Justin L Poklis, Stephen A Raso, Kylie N Alford, et al.
Journal of Analytical Toxicology
|
January 25, 2011
Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry
Justin L Poklis, Candace C Thompson, Kelly A Long, et al.
Journal of Analytical Toxicology
|
July 31, 2016
Identification of Drugs in Parenteral Pharmaceutical Preparations from a Quality Assurance and a Diversion Program by Direct Analysis in Real-Time AccuTOFTM-Mass Spectrometry (DART-MS)
Justin L Poklis, Amanda J Mohs, Carl E Wolf, et al.
Frontiers in Pharmacology
|
September 14, 2016
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes
Michelle R Peace, Karen E Butler, Carl E Wolf, et al.
Forensic Science International
|
January 12, 2017
Identification of MDMB-FUBINACA in commercially available e-liquid formulations sold for use in electronic cigarettes
Michelle R Peace, Rose I Krakowiak, Carl E Wolf, et al.
The International Journal of Neuropsychopharmacology
|
January 26, 2015
Preclinical Assessment of Lisdexamfetamine as an Agonist Medication Candidate for Cocaine Addiction: Effects in Rhesus Monkeys Trained to Discriminate Cocaine or to Self-Administer Cocaine in a Cocaine Versus Food Choice Procedure
Matthew L Banks, Blake A Hutsell, Bruce E Blough, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 135) with videos related to
Sort By:
Page
of 14
The Journal of Pharmacology and Experimental Therapeutics
|
June 15, 2010
Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet
Krishna M Boini, Chun Zhang, Min Xia, et al.
Journal of Clinical Laboratory Analysis
|
July 20, 2012
Detection and quantification of tricyclic antidepressants and other psychoactive drugs in urine by HPLC/MS/MS for pain management compliance testing
Justin L Poklis, Carl E Wolf, Ashley Goldstein, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 27, 2017
Ethanol Reversal of Tolerance to the Antinociceptive Effects of Oxycodone and Hydrocodone
Joanna C Jacob, Justin L Poklis, Hamid I Akbarali, et al.
Drug Testing and Analysis
|
September 4, 2013
Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication
Justin L Poklis, Carol R Nanco, Michelle M Troendle, et al.
Journal of Analytical Toxicology
|
September 18, 2015
Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper
Justin L Poklis, Stephen A Raso, Kylie N Alford, et al.
Journal of Analytical Toxicology
|
January 25, 2011
Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry
Justin L Poklis, Candace C Thompson, Kelly A Long, et al.
Journal of Analytical Toxicology
|
July 31, 2016
Identification of Drugs in Parenteral Pharmaceutical Preparations from a Quality Assurance and a Diversion Program by Direct Analysis in Real-Time AccuTOFTM-Mass Spectrometry (DART-MS)
Justin L Poklis, Amanda J Mohs, Carl E Wolf, et al.
Frontiers in Pharmacology
|
September 14, 2016
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes
Michelle R Peace, Karen E Butler, Carl E Wolf, et al.
Forensic Science International
|
January 12, 2017
Identification of MDMB-FUBINACA in commercially available e-liquid formulations sold for use in electronic cigarettes
Michelle R Peace, Rose I Krakowiak, Carl E Wolf, et al.
The International Journal of Neuropsychopharmacology
|
January 26, 2015
Preclinical Assessment of Lisdexamfetamine as an Agonist Medication Candidate for Cocaine Addiction: Effects in Rhesus Monkeys Trained to Discriminate Cocaine or to Self-Administer Cocaine in a Cocaine Versus Food Choice Procedure
Matthew L Banks, Blake A Hutsell, Bruce E Blough, et al.
Page
of 14